mail
versión imprimible
 
 

Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
14.12.2021 - 15.12.2021  Online
Time: 8:30 am - 6:15 pm
 
Temas de la conferencia
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community.

The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/867375-3?pid=4832

Speakers: Allyson Berent Chief Operating Officer | FAST GeneTx | Biotherapeutics Chief Scientific Officer, Anish Bhatnagar Chief Executive Officer Soleno Therapeutics and more
 

Información e inscripción:

https://go.evvnt.com/867375-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference Only - Drug Developer: USD 2099.00, Conference Only - Academic: USD 1899.00, Conference Only - Service Provider: USD 2599.00
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteCenter of ExcellenceÄrzte der WeltCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrztekammer für WiennewTree